Introduction {#sec1-1}
============

Obesity and being overweight are increasingly being recognized as major public health problems. More than two-thirds of adults in the United States are overweight or obese and the overall rates have doubled since 1970\'s.\[[@ref1]\] Traditionally, body mass index (BMI) has been shown to be positively associated with poor outcomes; however, paradoxical J-shaped relationship of BMI with outcomes is a well-known phenomenon in various populations.\[[@ref2]\] In pursuit of an explanation for the BMI paradox, cardiorespiratory fitness has been studied\[[@ref3]\] as it is theoretically possible that the BMI paradox could be explained by high muscle mass leading to high BMI which could be reflected by fitness. In a recent meta-analysis\[[@ref4]\] exploring the role of fitness, determined by maximal VO~2~ exercise testing and obesity in mortality; it has been shown that fitness ameliorates the deleterious effects of overweight and obesity. While maximal VO~2~ exercise testing gives the most comprehensive cardiorespiratory fitness information, it is a relatively sophisticated assay. Six-minute walk distance (SMWD) testing, on the other hand, is a very simple test which has been shown to provide prognostic performance comparable to maximal VO~2~ exercise testing.\[[@ref5]\] In patients with systolic heart failure, fitness determined by SMWD has also been demonstrated to modify paradoxical relationship between BMI and mortality.\[[@ref6]\]

In lung transplant recipients, BMI has been reported to have an increased association with mortality\[[@ref4][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]\] and grade 3 primary graft dysfunction.\[[@ref13]\] The paradoxical relationship between BMI and mortality, as well as, impact of SMWD on the BMI--mortality relationship has never been described in a lung transplant recipient cohort. Accordingly, the objectives of this study were to i) investigate impact of BMI as categorized by the National Heart, Lung and Blood Institute (NHLBI) classification on all-cause mortality and ii) inspect the interaction of SMWD with BMI and all-cause mortality in lung transplant recipients.

Methods {#sec1-2}
=======

Study design and population {#sec2-1}
---------------------------

This is a single-center, retrospective, observational study of consecutive patients who underwent isolated lung transplantation between June 2007 and February 2013. Patients with multiorgan transplantation were excluded. A final cohort of 324 isolated lung transplant recipients was included in the study. Regulatory approval was obtained from theInstitutional Review Board of our institution.

Patient characteristics {#sec2-2}
-----------------------

Data was retrieved from the Houston Methodist Hospital\'s lung transplant clinical database. Baseline patient characteristics and perioperative data were collected. We categorized primary lung pathology according to United Network for Organ Sharing (UNOS) classification of lung diseases;\[[@ref14]\] Group A (obstructive lung diseases), Group B (pulmonary vascular diseases), Group C (cystic fibrosis or other immunodeficiency disorders), and Group D (restrictive lung diseases). In double lung transplant recipients, the ischemic time was an averageof the ischemic time of each lung. History of coronary artery disease (CAD) was obtained by review of the medical record documentation (*n* = 44) and data from available preoperative coronary angiography results (*n* = 280). Presence of coronary plaque of any severity satisfied the definition of CAD. Smoking history was defined as any amount of cigarette smoking regularly prior to the lung transplantation. Preoperative oxygen support was determined at rest at the time of index hospitalization.

Classification of BMI {#sec2-3}
---------------------

The BMI data used in the analysis was collected at time of index hospital admission for lung transplant surgery. BMI classification was followed according to the NHLBI categories.\[[@ref15]\] Normal BMI was defined as BMI 18.5-24.9kg/m^2^. Underweight was defined as BMI \<18.5kg/m^2^. Overweight was defined as BMI 25.0-29.9kg/m^2^ and obese was defined as BMI 30kg/m^2^. Normal BMI was used as a reference group for the analyses.

Six-minute walk distance (SMWD) {#sec2-4}
-------------------------------

At least one SMWD within 6 months of transplantation was available for most patients, except for the transferred patients on mechanical ventilation or extracorporeal membrane oxygenation (ECMO) machine at the time of listing and did not have prior SMWD evaluation performed (*n* = 7). In that case, SMWD was determined as 0 to reflect the poorest-performing pretransplant functional status group. SMWD was not routinely repeated if there was no significant change in functional status per patients\' reports during pretransplant clinic visits. If SMWD was repeated and there were multiple SMWD data in one patient, the closest SMWD to lung transplantation was chosen for the analyses. The SMWD test employed a standard protocol by measuring the distance that patients were able to walk within a six-minute time limit. Patients are asked to cover as much distance as possible at a self-determined pace and were provided with enough oxygen to maintain a minimum oxygen saturation of 90% as measured by a portable pulse oximeter. The SMWD test was performed at the time of transplant evaluation by an experienced respiratory therapist using American Thoracic Society standards at a dedicated pulmonary function laboratory at Houston Methodist Hospital. In our lung transplant program; while regular exercise as tolerated was encouraged during pretransplant visits, there was not a routine pre-transplant rehabilitation program.

Study outcomes {#sec2-5}
--------------

The primary study outcome was all-cause mortality post-lung transplant surgery at any time point. Death was examined by systematically searching through medical record database, lung transplantation registry records, and social security death index. Time to death was enumerated from the date of the transplantation to the date of death.

Statistical analysis {#sec2-6}
--------------------

Descriptive statistics for studied variables are presented as mean with standard deviation (SD) for normally distributed continuous variables, median with interquartile range (IQR) for non-normally distributed continuous variables, and frequency with percentage for categorical variables. Independent Student\'s *t*-test and analysis of variance (ANOVA) were used to compare normally distributed continuous variables. Wilcoxon--Mann--Whitney U test and Kruskal--Wallis H test were utilized to compare non-normally distributed continuous variables. For comparison of categorical variables, chi-square and Fisher\'s exact tests were performed. The optimal cut-off SMWD value selected to determined cardiorespiratory fitness status was determined from a receiver operating characteristic (ROC), using maximal Youden index.

To assess for independent associations of BMI classifications and SMWD with mortality, univariate and multivariate Cox proportional regression analyses were performed. For SMWD, both continuous SMWD value after logarithmic transformation and dichotomous SMWD value using the optimal cut-off were examined in multivariate modeling. All covariates with *P*-value \< 0.10 in univariate modeling were included into a multivariate analysis. The regression analysis results are presented as HR with 95% confidence interval (CI). The adjusted Kaplan--Meier statistic survival curves categorized by BMI and SMWD were plotted.

All statistical analyses were performed with IBM Statistical Package for Social Sciences (SPSS)/PASW Statistics 20 (SPSS Inc, Chicago, IL). A two-tailed *P*-value of \<0.05 was considered statistically significant.

Results {#sec1-3}
=======

The final cohort was comprised of 324 recipients with a mean age of 57 ± 13 years and 58% were male. Primary lung pathologies were; obstructive lung diseases (Group A, 26.9%); pulmonary vascular diseases (Group B, 2.5%); cystic fibrosis or immunodeficiency disorders (Group C, 6.5%); and restrictive lung diseases (Group D, 64.2%). Median lung allocation score (LAS) prior to the lung transplantation was 38 (IQR 34-45). A minority of the patients (2.8%) were on mechanical ventilators or ECMO prior to the transplant. Double lung transplantation was performed in 62.3% of the patients with the mean ischemic time of 205 ± 66 minutes.

BMI classifications {#sec2-7}
-------------------

Mean BMI was 25.5 ± 5.4 kg/m^2^. Using the NHLBI BMI classification,\[[@ref2]\] 119 patients (36.7%) were categorized as having normal BMI. There were 32 underweight (9.9%), 109 overweight (33.6%), and 64 obese patients (19.8%). Differences in patient characteristics in each BMI classification are shown in [Table 1](#T1){ref-type="table"}. Statistically significant differences of the characteristics between the BMI classifications were observed in age (*P* \< 0.001), male gender (*P* = 0.011), primary pulmonary pathology (*P* \< 0.001), preoperative oxygen support (*P* = 0.031), and history of CAD (*P* = 0.019).

###### 

Clinical characteristics categorized by BMI classification

![](ATM-10-169-g001)

Six-minute walk distance (SMWD) {#sec2-8}
-------------------------------

The median SMWD of the whole cohort was 700 feet (IQR 305--1,018 feet). There were a total of nine ventilator/ECMO patients in our cohort. Of these patients, seven did not have prior SMWD data and their SMWD were determined as zero. The remaining two patients had SMWD of 600 and 100 feet. The median time interval between SMWD and lung transplantation was 30 days (IQR 9-99 days). The optimal cut-off SMWD value determined by ROC was 237 feet (sensitivity = 68%, specificity = 17%, Area under curve (AUC) = 0.58). Based on this cut-off, 66 patients (20.4%) were classified as lower SMWD (SMWD \<237 feet). Median SMWDs in the lower and higher SMWD groups were 81 feet (IQR 0-200 feet) and 850 feet (IQR 600-1,082 feet), respectively (*P* \< 0.001). Baseline demographics and operative data of the cohort, categorized by SMWD are summarized in [Table 2](#T2){ref-type="table"}. Between the lower and higher SMWD group, statistically significant differences were observed in primary lung pathology groups (*P* = 0.023), Preoperative O~2~ support at rest (*P* \< 0.001), preoperative mechanical ventilation or ECMO use (*P* \< 0.001), double lung transplantation (*P* = 0.030), LAS (*P* \< 0.001), serum creatinine (*P* \< 0.001) and postoperative vasopressor use (*P* = 0.031). There was no significant difference in proportion of patients in each BMI classifications among the two groups (*P* = 0.687).

###### 

Clinical characteristics classified by cardiorespiratory fitness
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Mortality rate and causes of death {#sec2-9}
----------------------------------

There were 71 patients (21.9%) who died during the median follow-up period of 2.3 years (IQR 1.0--3.6 years). The annualized mortality rate was significantly different among the BMI classifications (*P* = 0.005). The overweight group had the lowest mortality rate (5.6%/year) followed by normal BMI group (9.1%/year), obese group (14.3%/year), and underweight group (15.0%/year). Additionally, those who died had a significantly higher prevalence of unfitness (*P* = 0.007), cigarette smoking (*P* = 0.020), and higher LAS (*P* = 0.050). Other characteristics according to death and their mortality risks are shown in [Table 3](#T3){ref-type="table"}.

###### 

Clinical characteristics according to death and their mortality risk

![](ATM-10-169-g003)

Causes of death were available in 90% (64/71) of the patients. Deaths were due to 29 infections, 13 cardio-cerebrovascular causes, 8 graft failures, 8 respiratory failure, 4 operative bleedings, and 2 malignancies. The causes of death were not significantly different among different BMI groups (*P* = 0.73) as following: Normal BMI (11/23 infections, 3/23 cardio-cerebrovascular causes, 2/23 graft failures, 3/23 respiratory failure, 2/23 operative bleedings, and 2/23 malignancy), underweight (5/9 infections, 1/9 cardio-cerebrovascular causes, 1/9 graft failures and 2/9 respiratory failure), overweight (7/14 infections, 3/14 cardio-cerebrovascular causes, 2/14 graft failures and 2/14 respiratory failure), obese (6/18 infections, 6/18 cardio-cerebrovascular causes, 3/18 graft failures, 1/18 respiratory failure, 2/18 operative bleedings).

Predictors of mortality {#sec2-10}
-----------------------

Multivariate analysis of potential predictors for death is shown in [Table 3](#T3){ref-type="table"}. While the underweight patients were at higher risk of death compared to the normal BMI patients (HR 2.271, *P* = 0.040), the overweight patients had an approximate 50% reduced risk of death (HR 0.501, *P* = 0.042). The divergence in the survival curves began to show very early on after the transplantation and became relatively more stable after the first few months as shown in [Figure 1a](#F1){ref-type="fig"}. Subgroup analyses classified by SMWD showed that the inverse relationship between overweight and mortality was attenuated in the higher SMWD group (SMWD ≥237 feet; *P* = 0.552), but not the lower SMWD group (SMWD \<237 feet; HR 0.075, 95% CI 0.009-0.642, *P* = 0.018).

![Survival curves of lung transplant patients categorized by body mass index (a) and six-minute-walk distance (SMWD) (b)](ATM-10-169-g004){#F1}

Separate analyses evaluating the impact of BMI on early mortality (30-day mortality) showed that overweight was independently associated with increased mortality after lung transplantation (HR 0.20, 95% CI 0.04-0.93, *P* = 0.040) with adjustment for covariates with univariate *P* \< 0.10 (primary pulmonary pathology (*P* = 0.58), unfitness (HR 2.64, 95% CI 1.06-6.61, *P* = 0.038), and smoking history (HR 4.03, 95% CI 1.49-10.96, *P* = 0.006)). The risk of mortality associated with underweight, but not overweight, remained statistically significant after censoring 30-day death posttransplant (underweight HR 2.57, 95% CI 1.02-6.50, *P* = 0.046; overweight HR 0.67, 95%CI 0.31-1.43, *P* = 0.30; and obesity HR 1.37,95%CI 0.73-3.17, *P* = 0.27).

Other independent predictors for death were Group D, restrictive diseases (HR 2.391, *P* = 0.015) compared to Group A, obstructive diseases; lower SMWD (\<237 feet) HR 1.854, *P* = 0.050); and smoking history (HR 2.334, *P* = 0.001). SMWD value as continuous variable after logarithmic transformation was also independently associated with mortality in multivariate analysis (HR 0.692, 95% CI 0.524-0.913, *P* = 0.009) as shown in [Figure 1b](#F1){ref-type="fig"}.

Discussion {#sec1-4}
==========

The primary finding of this study is the overweight--mortality paradox in the lung transplant recipients. In our cohort, overweight patients experienced lower mortality than patients with normal BMI, underweight, or obese. This overweight paradox was attenuated when the analysis was performed in the patients with higher SMWD, but not in the patients with lower SMWD.

Previous studies investigating the impact of pretransplant BMI on mortality after lung transplantation have shown that BMI was positively associated with mortality.\[[@ref4][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]\] This includes the two studies\[[@ref7][@ref10]\] which examined the UNOS database between 1998-2008 and 1995-2003,respectively. Recent evidence,\[[@ref16]\] which investigated impact of BMI on mortality after implementation of LAS-based organ allocation system, also showed that class II--II obesity (BMI ≥35.0 kg/m^2^) was associated with increased 1-year mortality posttransplant. Other data from single-center studies with short-term mortality (90 days) and intermediate-long-term mortality also reported consistent findings.\[[@ref8][@ref11]\]

However, the controversial issue in regard to the association between BMI and mortality is in the overweight and underweight BMI ranges as current evidence is conflicting. A few studies have shown increased mortality risk associated with overweight and underweight patients;\[[@ref7][@ref10]\] while others have shown no significant relationship,\[[@ref4][@ref8][@ref9][@ref12]\] which included the study investigating lung transplantation under LAS-organ allocation system that showed increased mortality risk associated with undernutrition, but not overweight and class I obesity (BMI 30.0-34.9 kg/m^2^).\[[@ref16]\] In our study, we detected increased mortality associated with the underweight recipients compared to the normal BMI group. Our overweight group was paradoxically associated with a decreased mortality risk compared to the normal BMI group and this was primarily driven by early mortality (30 days). To the best of our knowledge, this paradoxical relationship has never been described in the lung transplant recipient population. We further examined the influence of SMWD on the overweight--mortality relationship. Currently after the establishment of LAS, the prognostic data of SMWD for mortality in lung transplant population is limited. The studies showing the prognostic value of SMWD in lung transplant patients were conducted prior to the LAS era.\[[@ref17][@ref18]\] Our study determined that SMWD, both as continuous variable and dichotomous variable (\< or ≥237 feet) based on ROC, was independently associated with mortality in multivariate analyses. Furthermore, by using the SMWD cut-off value of 237 feet, we demonstrated that the overweight--mortality paradoxical association was attenuated in the higher SMWD group. This interaction of SMWD and overweight--mortality paradox is consistent with multiple previous publications in other healthy and nontransplant disease cohorts.\[[@ref3]\]

Traditionally, increases in BMI have been shown to be positively associated with poor outcomes; however, paradoxical J-shaped relationship of BMI with outcomes is a well-known phenomenon in various populations;\[[@ref2][@ref19][@ref20][@ref21]\] including patients with chronic obstructive pulmonary disease and patients undergoing lung resection.\[[@ref22][@ref23]\] BMI is an overall index of body composition and it takes into account both fat and fat-free body mass. Recently in the literature, cardiorespiratory fitness has been used as a marker for fat-free body mass,\[[@ref3]\] since fit individuals should theoretically have higher BMI than those who are unfit due to increased muscle mass. This paradigm has been shown in previous literature to be a potential explanation for the obesity paradox in the fit patients.\[[@ref21]\] Nevertheless, the paradox still exists in the unfit patients for which the mechanisms are yet to be explained. In our study, we observed a survival advantage in overweight recipients compared to normal BMI recipients, but the trend is towards lower survival in obese recipients. This could potentially be explained by the time variance of dynamic changes between competing baseline overnutrition of the hosts versus undernutrition/wasting process secondary to chronic lung diseases leading to the transplant.\[[@ref24]\] Additionally, we also observed that the patients with higher SMWD had significantly higher normal-range serum creatinine levels compared to the patients with lower SMWD. This may reflect the amount of muscle mass in overweight subjects; however, further research is needed to prove this hypothesis.

The strength of our study is that the study is the first demonstration of the overweight--mortality paradox in a lung transplant recipient cohort and the demonstration of influence on the paradox by SMWD. SMWD-determined fitness has been shown to have important prognostic value in lung transplant candidates before LAS.\[[@ref17][@ref18]\] The low cost intervention to improve fitness is regular exercise. Exercise in lung transplant recipients has been shown to have a positive effect on maximal and functional exercise capacity, skeletal muscle function, bone mass density, and health-related quality of life.\[[@ref25]\] Our study additionally provides evidence that higher SMWD prior to lung transplantation is associated with survival benefit post-lung transplantation under LAS-based organ allocation system. This current study can be an incentive for prescribing a structured exercise regimen to all patients listed for lung transplantation; however, our findings need confirmation from larger randomized prospective studies and future research should also focus on effect of pretransplant structured rehabilitation on SMWD and clinical outcomes following the transplant.

We acknowledge some limitations in our study. While our data was from one of the largest single-center cohorts in the field, the number of patients was still modest and the risk of type II error should be considered. Second, we used SMWD as the surrogate for cardiorespiratory fitness instead of a cardiopulmonary test, the most scientifically accepted method to evaluate for fitness. While SMWD is a well-known prognosticator in COPD patients, the prognostic data of SMWD in lung transplant population under LAS is limited; however, we demonstrated the prognostic value of SMWD under LAS in this present study. Third, although the preoperative SMWD value used in the study was consistent with current UNOS guidelines, it is a one-time measurement; therefore the chronicity of the disease and potential effect of exercise leading to changes in SMWD could not be ascertained. This may also be a potential confounding factor as patients with rapid course of illness may still retain beneficial effects of fitness from respective healthy state and vice versa. Last, BMI is an overall index of body composition. A more specific marker of body composition such as dual-energy X-ray absorptiometry, which was not available in our study, should be considered in future studies.

Conclusion {#sec1-5}
==========

In lung transplant recipients under LAS era, pretransplant BMI and SMWD were independent predictors for mortality after the transplant. The lowest mortality risk was noted in a group of transplant recipients identified as overweight, whereas being underweight or obese was associated with increased mortality. This paradoxical overweight--mortality relationship was diminished in the recipients with higher SMWD, but not in the lower SMWD group.
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